SCHEMBL20072464

SCHEMBL20072464

CCC(C)c1ncccc1OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.41
HRH1 P35367 1/20 0.41
KCNH2 Q12809 1/20 0.41
PLAU P00749 1/20 0.40
PDGFRB P09619 1/20 0.40
PDGFRA P16234 1/20 0.40
RAB9A P51151 3/20 0.39
NPC1 O15118 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
KMT2A Q03164 1/20 0.39
TRPM8 Q7Z2W7 2/20 0.38
PDE10A Q9Y233 1/20 0.38
NISCH Q9Y2I1 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA7 P43166 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22193253 0.86 GRM5 (0.44) MEN1LMNAKMT2ANISCHGRM5
SCHEMBL9963325 0.83 PLAU (0.46) CYP2D6HRH1KCNH2PLAUPDGFRB
SCHEMBL28761577 0.81 PLAU (0.46) CYP2D6HRH1KCNH2PLAUPDGFRB
SCHEMBL15157541 0.81 PLAU (0.42) CYP2D6HRH1KCNH2PLAUPDGFRB
SCHEMBL20621434 0.79 L3MBTL1 (0.38) RAB9ANPC1SMN1; SMN2NISCHACHE
SCHEMBL20535138 0.79 CTSA (0.47) RAB9ANPC1SMN1; SMN2LMNAKMT2A
SCHEMBL6954493 0.78 PLAU (0.46) CYP2D6HRH1KCNH2PLAUPDGFRB
SCHEMBL8429785 0.78 PLAU (0.42) CYP2D6HRH1KCNH2PLAUPDGFRB
SCHEMBL31125653 0.78 PLAU (0.46) CYP2D6HRH1KCNH2PLAUPDGFRB
SCHEMBL29808848 0.78 PLAU (0.46) CYP2D6HRH1KCNH2PLAUPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11225469-B2 Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2022-01-18 US disclosed
US-20180105508-A1 INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11225469-B2 Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof PHGDH, PGD, PGK1 CYP2D6 429/4885HRH1 85/4885KCNH2 3844/4885
US-20180105508-A1 INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF PHGDH, PGD, PGK1 CYP2D6 564/4885HRH1 89/4885KCNH2 3750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.